Obesity Trial, Recruiting NCT07262762 Sponsor: Cinnagen Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07262762
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older (male or female)
  • You are willing to read and sign a consent form agreeing to take part in the study
  • Your body mass index (a measure of body weight relative to height) is 30 or above, OR it is 27 or above and you have at least one health condition related to your weight (such as high blood pressure or type 2 diabetes)

Who may not be able to join:

  • You have used a type of medication called a GLP-1 agonist (such as semaglutide or liraglutide) in the past 6 months
  • You have Type 1 diabetes
  • You have any health condition or personal situation that could put you at risk or make it difficult for the trial team to collect reliable information (confirm with trial site)
  • You are currently pregnant or breastfeeding
  • You, or a close family member, have a history of a specific type of thyroid cancer called medullary thyroid carcinoma (MTC), or you have been diagnosed with a condition called multiple endocrine neoplasia syndrome type 2 (MEN 2)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cinnagen
Registry
ClinicalTrials.gov
Start date
11 November 2025
Est. completion
1 December 2025

Where this trial is recruiting

Iran

Primary endpoints

Proportion of patients with ≥5% weight loss

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov